Tag: Cancer: Misc.
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients
Landmark Women’s Health Study Saved From Funding Cuts
Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma
Melphalan/HDS efficacious, has favorable risk-benefit profile for unresectable metastatic uveal melanoma
Prevalence of Most Cancer Risk Factors Unchanged Before, After Pandemic
Prevalence of smoking continued to drop during pandemic, but prevalence of excess body weight, HPV vaccination remained stable
Annual Whole-Body, Low-Dose CT Aids Management of Smoldering Multiple Myeloma
One in 10 progressed solely with bone lesions, highlighting the importance of early detection
Cancer Mortality Continuing to Decline
Mortality declined steadily from 2001 through 2022, including during the COVID-19 pandemic
CT Exams in 2023 Projected to Result in 103,000 Future Cancers
Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers
Healthy Nutrition, Activity May Reduce Mortality Risk for Cancer Survivors
Adherence to American Cancer Society guidelines linked to lower mortality in nonsmoking survivors of obesity-related cancer
Recommendations Updated for Fertility Preservation in Cancer
Patients interested in or uncertain about fertility preservation should be referred to reproductive specialists
